Complement factor H polymorphism and age-related macular degeneration

Science

Volumn 308, Issue 5720, 2005, Pages 421-424

  Edwards, Albert O ^a   Ritter III, Robert ^a   Abel, Kenneth J ^a   Manning, Alisa ^a   Panhuysen, Carolien ^a   Farrer, Lindsay A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINO ACIDS; GENETIC ENGINEERING; PROTEINS;

AGE-RELATED MACULAR DEGENERATION (AMD); COMPLEMENT FACTOR H POLYMORPHISM; GENE ENCODING; SINGLE-NUCLEOTIDE POLYMORPHISM;

GENES;

COMPLEMENT FACTOR H; HISTIDINE; TYROSINE;

AGING;

AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 1Q; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTIDINE; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MACULAR DEGENERATION; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TYROSINE; VARIATION (GENETICS);

EID: 17244379811     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1110189     Document Type: Article

References (30)

1. R. Klein, B. E. Klein, S. C. Tomany, S. M. Meuer, C. H. Huang, Ophthalmology 109, 1767 (2002).
2. R. Klein, T. Peto, A. Bird, M. R. Vannewkirk, Am. J. Ophthalmol. 137, 486 (2004).
3. G. R. Abecasis et al., Am. J. Hum. Genet. 74, 482 (2004).
4. S. K. Iyengar et al., Am. J. Hum. Genet. 74, 20 (2004).
5. M. L. Klein et al., Arch. Ophthalmol. 116, 1082 (1998).
6. J. Majewski et al., Am. J. Hum. Genet. 73, 540 (2003).
7. J. H. Schick et al., Am. J. Hum. Genet. 72, 1412 (2003).
8. J. M. Seddon, S. L. Santangelo, K. Book, S. Chong, J. Cote, Am. J. Hum. Genet. 73, 780 (2003).
9. D. E. Weeks et al., Am. J. Hum. Genet. 75, 174 (2004).
10. Materials and methods are available as supporting material on Science Online.
11. D. W. Schultz et al., Hum. Mol. Genet. 12, 3315 (2003).
12. D. J. Schaid, C. M. Rowland, D. E. Tines, R. M. Jacobson. G. A. Poland, Am. J. Hum. Genet. 70, 425 (2002).
13. H. Zhao, R. Pfeiffer, M. H. Gail, Pharmacogenomics 4, 171 (2003).
14. J. Acosta, X. Qin, J. Halperin, Curr. Pharm. Des. 10, 203 (2004).
15. H. J. Muller-Eberhard, R. D. Schreiber, Adv. Immunol. 29, 1 (1980).
16. R. F. Mullins, S. R. Russell, D. H. Anderson, G. S. Hageman, FASEB J. 14, 835 (2000).
17. L. V. Johnson, W. P. Leitner, M. K. Staples, D. H. Anderson, Exp. Eye Res. 73, 887 (2001).
18. E. Giannakis et al., Eur. J. Immunol. 33, 962 (2003).
19. J. M. Seddon, C. Gensler, R. C. Milton, M. L. Klein, N. Rifai, JAMA 291, 704 (2004).
20. C. Mold, H. Gewurz, T. W. Du Clos, Immunopharmacology 42, 23 (1999).
21. J. M. Seddon, J. Cote, N. Davis, B. Rosner, Arch. Ophthalmol. 121, 785 (2003).
22. J. Esparza-Gordillo et al., Immunogenetics 56, 77 (2004).
23. J. R. Greenfield et al., Circulation 109, 3022 (2004).
24. J. M. Backes, P. A. Howard, P. M. Moriarty, Ann. Pharmacother. 38, 110 (2004).
25. M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol. 27, 2351 (2000).
26. R. F. Mullins, N. Aptsiauri, G. S. Hageman, Eye 15, 390 (2001).
27. M. A. Dragon-Durey et al., J. Am. Soc. Nephrol. 15, 787 (2004).
28. D. S. Friedman et al., Arch. Ophthalmol. 122, 564 (2004).
29. J. C. Barrett, B. Fry, J. Maller, M. J. Daly, Bioinformatics 21, 263 (2005).
30. We thank the McDermott Sequencing Center at UTSWMC for genotyping assistance and T. Hyatt for technical advice and assistance. Supported by the National Eye Institute (EY014467), a center grant from the Foundation Fighting Blindness, and Research to Prevent Blindness.